Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
219.7 USD | +0.37% | +2.28% | -15.09% |
05-08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
05-07 | FDA Sets June 10 Advisory Panel Meeting on Eli Lilly Alzheimer's Drug | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.09% | 31.87B | |
-2.35% | 89.33B | |
+4.08% | 41.19B | |
+53.68% | 24.52B | |
-15.13% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B | |
-6.45% | 7.52B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : RBC Cuts Price Target on Biogen to $295 From $325, Maintains Sector Perform Rating